Advanced search
Publication Cover
Cancer Management and Research Volume 10, 2018 - Issue
Submit an article Journal homepage
219
Views
42
CrossRef citations to date
0
Altmetric
Original Research

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma

Hongda Chen1 National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected]
,
Yue Zhang1 National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected];2 Office of Scientific Research, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
,
Siwen Li3 Liver Research Center, Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, Beijing, China, [email protected]
,
Ni Li1 National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected]
,
Yuhan Chen4 Department of Gastrointestinal and Hepatology, Beijing You’ An Hospital Affiliated to Capital Medical University, Beijing, China
,
Bei Zhang3 Liver Research Center, Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, Beijing, China, [email protected]
,
Chunfeng Qu1 National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected]
,
Huiguo Ding4 Department of Gastrointestinal and Hepatology, Beijing You’ An Hospital Affiliated to Capital Medical University, Beijing, China
,
Jian Huang3 Liver Research Center, Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, Beijing, China, [email protected];5 National Clinical Research Center of Digestive Diseases, Beijing, China, [email protected]Correspondence[email protected]
&
Min Dai1 National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected]Correspondence[email protected]
 show all
Pages 1947-1958 | Published online: 10 Jul 2018

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Xiaoling Long, Huan Zeng, Yun Zhang, Qiulong Lu, Zhao Cao & Hong Shu. (2024) Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions. Journal of Hepatocellular Carcinoma 11, pages 607-618.
Read now
Chenlu Lan, Xinlei Huang, Xiwen Liao, Xin Zhou, Kai Peng, Yongguang Wei, Chuangye Han, Tao Peng, Jianyao Wang & Guangzhi Zhu. (2023) PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Pharmacogenomics and Personalized Medicine 16, pages 337-355.
Read now
Bing-yao Pang, Yan Leng, Xiaoli Wang, Yi-qiang Wang & Li-hong Jiang. (2023) A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma. Annals of Medicine 55:1, pages 42-61.
Read now
Yanjun Shen, Yawen Xu, Jianying Wei & Wendong Li. (2022) The Prognostic Role of Circulating FPR Before Operation in Patients with BCLC A-C Hepatocellular Carcinoma: A Retrospective Cohort Study. Journal of Hepatocellular Carcinoma 9, pages 467-476.
Read now
Yong-Sheng Fang, Qiang Wu, Hong-Chuan Zhao, Yuan Zhou, Lei Ye, Sheng-Sheng Liu, Xiao-Xue Li & Wei-Dong Du. (2021) Do combined assays of serum AFP, AFP-L3, DCP, GP73, and DKK-1 efficiently improve the clinical values of biomarkers in decision-making for hepatocellular carcinoma? A meta-analysis. Expert Review of Gastroenterology & Hepatology 15:9, pages 1065-1076.
Read now
AA Mohamed, D Omran, S El-Feky, H Darwish, AEL Kassas, A Farouk, O Ezzat, SM Abdo, FE Zahran, A El-Demery & MM Omran. (2021) Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index. British Journal of Biomedical Science 78:1, pages 18-22.
Read now
Miaoxia Liu, Ruihong Wu, Xu Liu, Hongqin Xu, Xiumei Chi, Xiaomei Wang, Mengru Zhan, Bao Wang, Fei Peng, Xiuzhu Gao, Ying Shi, Xiaoyu Wen, Yali Ji, Qinglong Jin & Junqi Niu. (2020) Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients. Journal of Hepatocellular Carcinoma 7, pages 219-232.
Read now
Tao Li, Hongguang Li, Aihua Wang, Xiaoyan Su, Jingfang Zhao, Yi Cui, Jun Liu & Jinhua Hu. (2019) Development And Validation Of A Simple Model For Detection Of Early Hepatocellular Carcinoma In A Liver Cirrhosis Cohort. Cancer Management and Research 11, pages 9379-9386.
Read now

Articles from other publishers (34)

Zhou Yu, Dongmei Chen, Yansong Zheng, Xuedan Wang, Shuna Huang, Tiansheng Lin, Yihan Lin, Yanfang Zhang, Yingna Huang, Qishui Ou & Jinlan Huang. (2023) Development and validation of a diagnostic model for AFP-negative hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 149:13, pages 11295-11308.
Crossref
Chanida Puangpila, Nattakritta Anukulkich, Siraphatsorn Chiapleam, Benyarat Intajan, Jaroon Jakmunee & Somkid Pencharee. (2023) Development of lectin‐based lateral flow assay for fucosylated alpha‐fetoprotein. Journal of Cellular Biochemistry 124:10, pages 1546-1556.
Crossref
Onyinye Ugonabo, Utibe-Abasi Sunday Udoh, Pradeep Kumar Rajan, Heather Reeves, Christina Arcand, Yuto Nakafuku, Tejas Joshi, Rob Finley, Sandrine V. Pierre & Juan Ramon Sanabria. (2023) The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions. Biomolecules 13:9, pages 1369.
Crossref
Zhiyong Du, Shengju Yin, Bing Liu, Wenxin Zhang, Jiaxu Sun, Meng Fang, Yisheng Xu, Kun Hua, Pengfei Tu, Guoliang Zhang, Ying Ma & Yingyuan Lu. (2023) Metabolomics and network analysis uncovered profound inflammation-associated alterations in hepatitis B virus-related cirrhosis patients with early hepatocellular carcinoma. Heliyon 9:5, pages e16083.
Crossref
Lin Wang, Hui Shi, Jia Wei, Wen-Xiu Chen, Yue-Xinzi Jin, Chun-Rong Gu, Yuan Mu, Jian Xu & Shi-Yang Pan. (2023) SP70 is a novel biomarker of hepatocellular carcinoma. Frontiers in Oncology 13.
Crossref
Mirela Georgiana Perne, Adela-Viviana Sitar-Tăut, Teodora Gabriela Alexescu, Lorena Ciumărnean, Mircea-Vasile Milaciu, Sorina-Cezara Coste, Calin-Vasile Vlad, Angela Cozma, Dan-Andrei Sitar-Tăut, Olga Hilda Orăşan & Alexandra Crăciun. (2023) Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Diagnostics 13:5, pages 816.
Crossref
Guoming Chen, Cheng Zhang, Danyun Li, Dongqiang Luo, Hui Liao, Peizhen Huang, Ning Wang & Yibin Feng. (2023) HAMP as a Potential Diagnostic, PD-(L)1 Immunotherapy Sensitivity and Prognostic Biomarker in Hepatocellular Carcinoma. Biomolecules 13:2, pages 360.
Crossref
Zuyuan Lin, Huigang Li, Chiyu He, Modan Yang, Hao Chen, Xinyu Yang, Jianyong Zhuo, Wei Shen, Zhihang Hu, Linhui Pan, Xuyong Wei, Di Lu, Shusen Zheng & Xiao Xu. (2023) Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma. Frontiers in Oncology 13.
Crossref
Xiaowei Chi, Liejun Jiang, Yulin Yuan, Xinyan Huang, Xuemei Yang, Steven Hochwald, Jie Liu & Huayi Huang. (2022) A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China. BMC Gastroenterology 22:1.
Crossref
Zhongjing Kang, Kai Jin & Junpeng Jing. (2022) The Value of MRI Combined with AFP, AFP-L3, GP73, and DCP in the Diagnosis of Early Primary Liver Cancer. Disease Markers 2022, pages 1-5.
Crossref
Hoang Bac Nguyen, Xuan-Thao Thi Le, Huy Huu Nguyen, Thanh Thanh Vo, Minh Khoi Le, Ngan Trung Nguyen, Thien Minh Do-Nguyen, Cong Minh Truong-Nguyen & Bang-Suong Thi Nguyen. (2022) Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related. Cancer Informatics 21, pages 117693512211007.
Crossref
Jian-Ming Zhou, Ting Wang & Kun-He Zhang. (2021) AFP-L3 for the diagnosis of early hepatocellular carcinoma. Medicine 100:43, pages e27673.
Crossref
Darmadi Darmadi, Riska Habriel Ruslie & Cennikon Pakpahan. (2021) Vascular Endothelial Growth Factor Levels Difference among Hepatocellular Cancer Patients Based on Barcelona Clinic Liver Cancer Staging. Open Access Macedonian Journal of Medical Sciences 9:B, pages 797-800.
Crossref
Devalingam Mahalingam, Leonidas Chelis, Imran Nizamuddin, Sunyoung S. Lee, Stylianos Kakolyris, Glenn Halff, Ken Washburn, Kristopher Attwood, Ibnshamsah Fahad, Julia Grigorieva, Senait Asmellash, Krista Meyer, Carlos Oliveira, Heinrich Roder, Joanna Roder & Renuka Iyer. (2021) Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based Test. Cancers 13:13, pages 3109.
Crossref
Mengtao Xing, Xinzhi Wang, Robert Kirken, Ling He & Jian-Ying Zhang. (2021) Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment. International Journal of Molecular Sciences 22:11, pages 6139.
Crossref
Shipeng Chen, Zihan Zhang, Ying Wang, Meng Fang, Jun Zhou, Ya Li, Erhei Dai, Zhaolei Feng, Hao Wang, Zaixing Yang, Yongwei Li, Xianzhang Huang, Jian’an Jia, Shuang Li, Chenjun Huang, Lin Tong, Xiao Xiao, Yutong He, Yong Duan, Shanfeng Zhu & Chunfang Gao. (2021) Using Quasispecies Patterns of Hepatitis B Virus to Predict Hepatocellular Carcinoma With Deep Sequencing and Machine Learning. The Journal of Infectious Diseases 223:11, pages 1887-1896.
Crossref
Ankita Singh, Vipul Ranjan, Rina Das, Karun Bhatti, Dinesh Kumar Mehta & Ram Mohan Chidurala. (2021) Serum Biomarkers for Noninvasive Diagnosis of Liver Diseases: How Laudable are These Tools?. Current Chemical Biology 15:2, pages 128-138.
Crossref
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac & Giovanni Casazza. (2021) Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2021:4.
Crossref
Ruwanthi Kolamunnage-Dona & Adina Najwa Kamarudin. (2020) Adjustment for the measurement error in evaluating biomarker performances at baseline for future survival outcomes: Time-dependent receiver operating characteristic curve within a joint modelling framework. Research Methods in Medicine & Health Sciences 2:2, pages 51-60.
Crossref
Amr Shaaban Hanafy, Mohamed Sorour Mohamed & Ahmed A. Alnagar. (2020) Ascitic Calprotectin as an early predictor of hepatocellular carcinoma in patients with cirrhotic ascites. Journal of Cancer Research and Clinical Oncology 146:12, pages 3207-3214.
Crossref
Jia Fan, Yu Chen, Dan Zhang, Juan Yao, Zijun Zhao, Yao Jiang, Yiqin Li & Yongcan Guo. (2020) Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis. Surgical Oncology 34, pages 245-255.
Crossref
Weiyi Wang & Chao Wei. (2020) Advances in the early diagnosis of hepatocellular carcinoma. Genes & Diseases 7:3, pages 308-319.
Crossref
Ting Wang & Kun-He Zhang. (2020) New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma. Frontiers in Oncology 10.
Crossref
Takako Inoue & Yasuhito Tanaka. (2020) Novel biomarkers for the management of chronic hepatitis B. Clinical and Molecular Hepatology 26:3, pages 261-279.
Crossref
Ting Song, Lili Wang, Bin Su, Weiping Zeng, Taiyi Jiang, Tong Zhang, Guizhen Sun & Hao Wu. (2019) Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma . Journal of International Medical Research 48:3, pages 030006051988927.
Crossref
Xi Zhang, Ting Wang, Kun-He Zhang, Si-Hai Chen, Yu-Ting He & Yu-Qi Wang. (2020) Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels. Frontiers in Oncology 9.
Crossref
Harpreet Kaur, Anjali Dhall, Rajesh Kumar & Gajendra P. S. Raghava. (2020) Identification of Platform-Independent Diagnostic Biomarker Panel for Hepatocellular Carcinoma Using Large-Scale Transcriptomics Data. Frontiers in Genetics 10.
Crossref
Tomonari Shimagaki, Sachiyo Yoshio, Hironari Kawai, Yuzuru Sakamoto, Hiroyoshi Doi, Michitaka Matsuda, Taizo Mori, Yosuke Osawa, Moto Fukai, Takeshi Yoshida, Yunfei Ma, Tomoyuki Akita, Junko Tanaka, Akinobu Taketomi, Rikinari Hanayama, Tomoharu Yoshizumi, Masaki Mori & Tatsuya Kanto. (2019) Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Scientific Reports 9:1.
Crossref
Н. Р. Матковська. (2019) Analysis of Causes of Death in Patients with Alcoholic Liver Cirrhosis Associated with Non-alcoholic Fatty Liver Disease. Family medicine:4, pages 47-50.
Crossref
N. R. Matkovska. (2019) MORTALITY ANALYSIS OF THE PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS. International Journal of Medicine and Medical Research 5:1, pages 40-46.
Crossref
Lavinia Alice Balaceanu. (2019) Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis . World Journal of Clinical Cases 7:12, pages 1367-1382.
Crossref
Chunfeng QuYuting WangPei WangKun ChenMinjie WangHongmei ZengJianquan LuQianqian SongBill H. Diplas, Da TanChunsun FanQigao GuoZheng ZhuHuihui YinLiping JiangXixi ChenHui ZhaoHuan HeYong WangGuangyu LiXinyu BiXinming ZhaoTaoyang ChenHongping TangChuanguo LvDongmei WangWanqing ChenJianguo ZhouHong ZhaoJianqiang CaiXiaoyue WangSizhen WangHai YanYi-Xin ZengWebster K. Cavenee & Yuchen Jiao. (2019) Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy. Proceedings of the National Academy of Sciences 116:13, pages 6308-6312.
Crossref
Zuojian Hu, Huaping Chen, Siyuan Chen, Zhili HuangShanzi Qin, Jianing Zhong, Xue Qin & Shan Li. (2019) The value of neutrophil to lymphocyte ratio and gamma-glutamyl transpeptidase to platelet ratio in patients with hepatocellular carcinoma. Medicine 98:9, pages e14749.
Crossref
Guoming Chen, Cheng Zhang, Danyun Li, Dongqiang Luo, Hui Liao, Peizhen Huang, Ning Wang & Yibin Feng. (2022) HAMP Is a Potential Diagnostic, PD-(L)1 Immunotherapy Sensitivity and Prognostic Biomarker in Hepatocellular Carcinoma. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.